InvestorsHub Logo
Followers 29
Posts 2647
Boards Moderated 0
Alias Born 07/26/2016

Re: williamssc post# 386533

Monday, 12/27/2021 5:24:49 PM

Monday, December 27, 2021 5:24:49 PM

Post# of 402865
Yessss.

By the way, what's your guess at the first pps driver of the New Year (assuming we have one). Mine is Alfasigma, around mid year with a successful Ph2b. If strong enough, they could be buyers of the whole IPIX IBD franchise (I may be hoping here more than expecting.); or maybe they just wait to finish the 3 before they decide what, if anything, they will do.
As time passes I seem to get more disturbed at the shell company we own, no office, no staff and no lab, no post docs, etc. Imagine what lab testing re Brilicadin for MRSA could turn up (or not). Just an enema and IV so far, both useful, but of limited treatment perspective in the longer term (i.e no pills, injections, etc.). But I can't minimize the spit and swish for OM, just what it should be, ideally, for an inexpensive, effective place in a hospital formulary, if it ever gets funded for a Ph3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News